Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Regarding Japanese primary aldosteronism, the low, intermediate, and high renin change groups (classified based on the response of renin to mineralocorticoid antagonist treatment) had CVD incidence of 2.1%, 0.5%, and 3.7%, respectively, during the 5-year study period.
27 million Japanese are hypertensive disease and 89.6% of them are treated with any anti-hypertensive medications. This is the first study utilizing the National Database of Health Insurance Claims and Specific Health Checkups to determine the number and age-adjusted prevalence of hypertensive patients and treated hypertensive patients in Japan.
Orthostatic and nocturnal changes in systolic blood pressure are inversely associated in older adults, probably due to aging-related autonomic nervous system deficits.
(A) The prevalence of PA was 6.1% of the total population. Among 55 patients with conclusive subtype differentiation of PA, 27% had APA, 65% had BAH, and 7% had UAH. (B) Patients with PA had a higher blood pressure and higher prevalence of target-organ damage than patients without PA. APA, aldosterone-producing adenoma; BAH, bilateral adrenal hyperplasia; ECG, electrocardiogram; LVH, left ventricular hypertrophy; PA, primary aldosteronism; SBP, systolic blood pressure; UAH, unilateral adrenal hyperplasia.
Twenty-four-hour urinary cortisol excretion is best associated with a decrease in the lumbar spine bone density via increased adrenal cortisol overproduction. DST overnight dexamethasone suppression test.
The impact of intrauterine hypoxia on acetylcholine (ACh)-mediated endothelium dependent vasodilatation in fetal sheep middle cerebral artery (MCA). Intrauterine hypoxia decreased CHRM3 expression, and inhibited NOS3 bioactivities due to ROS over-production and ERK1/2 inhibition, leading to MCA dysfunction.